Formulation Development Applications & Studies

  1. Optimization And Scale-Up Of A Plasmid DNA Production Process 9/30/2025

    Optimizing pDNA production in E. coli requires strategic media selection and scale-up planning. Explore a study that identifies ideal conditions for high-yield manufacturing.

  2. Thermofluor Screening For Injectable Protein Formulations 9/15/2025

    The results herein highlight thermofluor screening as a versatile and efficient platform for rational formulation of injectable biologics through the acceleration of stable drug product development.

  3. Phenotypic Characterization Of Bleomycin-Induced Pulmonary Fibrosis Mod 9/8/2025

    To gain deeper biological insight, lung injury in this model has been further characterized through cellular phenotyping, gene expression analysis, and cytokine profiling.

  4. Decoding The Conformational Plasticity Of Ternary Complexes For Protacs' Differential Activity 9/8/2025

    Leverage our insights into PROTAC ternary complex plasticity and stability to accelerate the design of next-generation therapeutics.

  5. Scalable Production Of High-Purity Nanobodies Using Yeast Expression System 9/8/2025

    Leverage scalable K. pastoris expression systems to produce high-quality nanobodies for cutting-edge therapeutic, diagnostic, and research applications.

  6. Streptozotocin-Induced Diabetic Peripheral Neuropathic Pain Model 9/8/2025

    Emerging research highlights that insulin deficiency drives sensory neuropathy, and early insulin therapy may help prevent or alleviate chronic diabetic neuropathic pain.

  7. Understanding Biotherapeutic Peptides And GLP-1 Receptor Agonists 9/2/2025

    Biotherapeutic peptides offer enhanced safety and efficacy over traditional drugs. Learn why rigorous impurity profiling is vital to ensure product quality, patient safety, and regulatory compliance.

  8. Overcoming Excipient Risks And Challenges For Parenteral Formulations 8/27/2025

    Excipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.

  9. Validation Provider Shortens The Path To Equipment Qualification 8/19/2025

    Explore the partnership enabling Transcat to meet regulatory requirements while focusing on core R&D and accelerating the delivery of life-changing therapies.

  10. Seed Train Intensification Using High Cell Density Cryopreservation 8/11/2025

    Streamline your upstream bioprocessing with seed train intensification. Discover how high cell density cryopreservation reduces scale-up time, boosts consistency, and enhances manufacturing flexibility.